IFNG and COVID-19: Recent in-vitro data from COVID-19 patients with active pulmonary tuberculosis has shown an attenuated interferon-gamma response after stimulation of whole blood with peptides derived from SARS-CoV-2 spike protein, in contrast to a normal response to Mycobacterium tuberculosis-specific antigens [78].